2023 annual financial data
Vivos Therapeutics 2023 Operating margin
Vivos Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was -125.32%.
Operating income was -17,296,000 USD and net income was -13,583,000 USD.
Operating cash flow was -11,946,000 USD.
Get free Vivos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 13,801,000 USD
- Operating income
- -17,296,000 USD
- Net income
- -13,583,000 USD
- Operating cash flow
- -11,946,000 USD